Researchers have developed and internally validated prediction models designed to identify patients with psoriasis at increased risk for psoriatic arthritis.
Researchers have developed and internally validated prediction models designed to identify patients with psoriasis at increased risk for psoriatic arthritis.
Although the IL-23/Th17 axis is recognized as a central driver of psoriasis, molecular heterogeneity across different ethnic populations has not been well characterized.
Although the IL-23/Th17 axis is recognized as a central driver of psoriasis, molecular heterogeneity across different ethnic populations has not been well characterized.
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated immune responses, with T cells playing a central role in disease pathogenesis.
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated immune responses, with T cells playing a central role in disease pathogenesis.
This interview highlights the importance of culturally sensitive care and the need for equitable access to treatment options for all patients, regardless of race or ethnicity.
This interview highlights the importance of culturally sensitive care and the need for equitable access to treatment options for all patients, regardless of race or ethnicity.
Alopecia areata (AA) is an autoimmune disease affecting approximately 160 million people worldwide.1 With AA, the immune system attacks hair follicles, resulting in hair loss and preventing hair regrowth.2 The standard approach to treating...
Alopecia areata (AA) is an autoimmune disease affecting approximately 160 million people worldwide.1 With AA, the immune system attacks hair follicles, resulting in hair loss and preventing hair regrowth.2 The standard approach to treating...
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...